|
Safety and Efficacy of a Heparin-Coated Intraocular Lens in Uveitis Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified health advice, visits or treatment with a real mD. We are not doctors. Always consult your doctor about Safety and Efficacy of a Heparin-Coated Intraocular Lens in Uveitis conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Safety and Efficacy of a Heparin-Coated Intraocular Lens in Uveitis Clinical research trials and Safety and Efficacy of a Heparin-Coated Intraocular Lens in Uveitis healthcare trials happen in many of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new drugs. The purpose of the studies / projects is to solve particular human medical questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to discover cures for all varieties of conditions, such as Safety and Efficacy of a Heparin-Coated Intraocular Lens in Uveitis. Safety and Efficacy of a Heparin-Coated Intraocular Lens in Uveitis Clinical Trials and other clinical trials allow volunteers to have health treatment alternatives before they are available to the masses. Some times the human subjects obtain treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Safety and Efficacy of a Heparin-Coated Intraocular Lens in Uveitis clinical trial. Test subjects oftentimes receive the most effective healthcare possible for their Safety and Efficacy of a Heparin-Coated Intraocular Lens in Uveitis condition. Dangers are a reality, however, and may include extra or frequent physician visits, healthcare dangers (possibly life-jeopardising), and/or the treatment being uneffective. Trials are federally governed with rigorous guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > Safety and Efficacy of a Heparin-Coated Intraocular Lens in Uveitis  Safety and Efficacy of a Heparin-Coated Intraocular Lens in Uveitis
Safety and Efficacy of a Heparin-Coated Intraocular Lens in Uveitis
For Condition: Cataract,Uveitis
Status: No longer recruiting
Sponsor(s): National Eye Institute (NEI) ,
Synopsis: To investigate the safety and efficacy of a heparin surface-modified intraocular lens in patients with uveitis undergoing cataract surgery. To evaluate the safety and efficacy of intraocular lens implantation in patients with severe uveitis.
Details: Patients with uveitis are at high risk for significant complications following cataract surgery with intraocular lens implantation. Complications may result from the surgery itself or may develop after surgery as a result of the intraocular lens. Complications related to intraocular lens implantation include iris adhesions to the intraocular lens, which can result in lens capture; cellular deposits on the surface of the lens that can obscure vision; and uveitis. Recent studies have identified giant cells on the anterior surface of intraocular lenses in some patients with uveitis, appearing to indicate an intraocular lens-induced inflammatory response. Some of these patients have required multiple YAG laser procedures to remove these deposits. Modification of the surface of the intraocular lens with a layer of heparin may provide a more biocompatible surface. Preclinical studies have shown a reduction in the degree of postoperative complications with the heparin surface-modified intraocular lens compared with an unmodified lens. Although retrospective case series have examined the use of heparin surface-modified intraocular lenses in patients with uveitis, a randomized, controlled clinical trial has not been performed. This is a randomized clinical trial examining the safety and efficacy of the heparin surface-modified intraocular lens in patients with uveitis. Eighty patients with a history of uveitis in an eye requiring cataract surgery will be randomized to receive a heparin surface-modified intraocular lens or the same model of intraocular lens without surface modification. The primary end point of the study will be the development of cellular deposits on the anterior surface of the intraocular lens 1 year after surgery. These cellular deposits will be assessed by a masked grader using standard photographs. Secondary end points will include visual acuity, intraocular inflammation, development of anterior and posterior synechiae, and corneal endothelial cell counts.
Eligibility:
Study Type: Interventional, Treatment, Randomized
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Women and men 18 years or older with a documented history of uveitis in an eye requiring cataract surgery are eligible for the study. In all patients, the eye must be free of active inflammation for at least 3 months before surgery, with or without anti-inflammatory medications. Exclusion criteria include corneal pathology or hazy media that preclude evaluation of the intraocular lens, uncontrolled glaucoma, and diabetes mellitus. Monocular patients and patients who cannot be followed for at least 1 year are also excluded.
Total Enrollment:
Location and Contact Information:
National Institutes of Health
Bethesda, Maryland, 20892-1858
United States
Additional Information:
Study ID Numbers: NEI-15;
Study Start Date: March 1994
Record last reviewed: September 1999
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00000119
Other Uveitis Studies:
1. Cyclosporin Implant to Treat Uveitis
2. Daclizumab to Treat Non-Infectious Sight-Threatening Uveitis
3. ANTI-TAC THERAPY FOR UVEITIS
4. Safety and Efficacy of a Heparin-Coated Intraocular Lens in Uveitis
5. HAT in Eye Complications of Behcet's Disease
Related Studies:
Other Uveitis Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Safety and Efficacy of a Heparin-Coated Intraocular Lens in Uveitis
|
|
|
|
|
|
|
|
